Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Weijia, Liao"'
Autor:
Xuanzhi Yan, Yicheng Li, Wanying Qin, Jiayi Liao, Jiaxing Fan, Yujin Xie, Zewen Wang, Siming Li, Weijia Liao
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Although radical surgical resection is the most effective treatment for hepatocellular carcinoma (HCC), the high rate of postoperative recurrence remains a major challenge, especially in patients with alpha-fetoprotein (AFP)-negat
Externí odkaz:
https://doaj.org/article/309cb76e84c24616b6e3cae3839f8ed2
Autor:
Dongbo Chen, Jie Gao, Liying Ren, Pu Chen, Yao Yang, Shaoping She, Yong Xie, Weijia Liao, Hongsong Chen
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 6337-6347 (2023)
Abstract Introduction Due to the high recurrence, the HCC prognosis remains poor. Yet, the biomarkers for predicting the recurrence of high‐risk patients are currently lacking. We aimed to develop a signature to predict the recurrence of HCC based
Externí odkaz:
https://doaj.org/article/1024eb5970e5483e903136cc9cdd62bd
Autor:
Jie Gao, Yao Yang, Pu Chen, Dongbo Chen, Dechao Bu, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Xingwang Xie, Weijia Liao, Hongsong Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Background Previous studies confirmed that most neoantigens predicted by algorithms do not work in clinical practice, and experimental validations remain indispensable for confirming immunogenic neoantigens. In this study, we identified the potential
Externí odkaz:
https://doaj.org/article/4c4a36e03b004f24a53a8297f686fb82
Autor:
Shuqun Li, Junyi Wu, Jiayi Wu, Yangkai Fu, Zhenxin Zeng, Yinan Li, Han Li, Weijia Liao, Maolin Yan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/93e80b089650477e99a078a5dcb39493
Autor:
Shuqun Li, Junyi Wu, Jiayi Wu, Yangkai Fu, Zhenxin Zeng, Yinan Li, Han Li, Weijia Liao, Maolin Yan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Background and aimThe purpose of this study was to investigate and validate the efficacy of a nomogram model in predicting early objective response rate (ORR) in u-HCC patients receiving a combination of TACE, Lenvatinib, and anti-PD-1 antibody treat
Externí odkaz:
https://doaj.org/article/a67381f31f89467e9ec477581042e83d
Autor:
Liying Ren, Dongbo Chen, Wentao Xu, Tingfeng Xu, Rongyu Wei, Liya Suo, Yingze Huang, Hongsong Chen, Weijia Liao
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Since it’s a challenging task to precisely predict the prognosis of patients with hepatocellular carcinoma (HCC). We developed a nomogram based on a novel indicator GMWG [(Geometric Mean of gamma-glutamyltranspeptidase (GGT) and
Externí odkaz:
https://doaj.org/article/6834a82087a741eabcbe50d735565395
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progressi
Externí odkaz:
https://doaj.org/article/ce0a9111d4684c88b3a5bba64d5fff63
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Liver fibrosis or cirrhosis is associated with the dismal prognosis of hepatocellular carcinoma (HCC), and it might also be involved in intrahepatic cholangiocarcinoma (ICC). The effect of hepatic fibrosis on the survival of ICC p
Externí odkaz:
https://doaj.org/article/048c42a39b4f4618a3276958fbded5a5
Autor:
Hongxing Zhang, Yu Zhou, Yicheng Li, Wanying Qin, Yunhua Zi, Yulan Liu, Xiaoying Qiu, Hongyuan Xu, Weijia Liao, Zhaoquan Huang
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Microvascular invasion (MVI) is an independent risk factor for poor prognosis in hepatocellular carcinoma (HCC). However, there is still a lack of preoperative markers to predict MVI in HCC. This study intends to explore the poten
Externí odkaz:
https://doaj.org/article/17d5c0f33de24eb98a81de4fba0093ed
Autor:
Minjun Liao, Jiarun Sun, Qifan Zhang, Cuirong Tang, Yuchen Zhou, Mingrong Cao, Tao Chen, Chengguang Hu, Junxiong Yu, Yangda Song, Meng Li, Weijia Liao, Yuanping Zhou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHepatocellular carcinoma (HCC) is one of the leading malignant tumors worldwide. Prognosis and long-term survival of HCC remain unsatisfactory, even after radical resection, and many non-invasive predictors have been explored for post-opera
Externí odkaz:
https://doaj.org/article/3f9e33aad7b84a0b9550b1fbbef219a5